Indiana Won't Sign Onto $48M Healthpoint FCA Deal

Law360, New York (December 20, 2012, 6:04 PM EST) -- Indiana officials on Wednesday asked a Massachusetts federal judge to reopen a False Claims Act whistleblower suit against Healthpoint Ltd. over improper billing for Xenaderm skin ointment, saying they've been unable to reach terms in a matter the federal government recently settled for $48 million.

Indiana's motion to revive the case, filed two weeks after the federal government announced a deal, says the state hasn't managed to come to a meeting of the minds with Healthpoint, a DFB Pharmaceuticals Inc. subsidiary accused of ripping off Medicare...
To view the full article, register now.




Case Information

Case Title

United States, ex rel v. Actavis Mid-Atlantic, et al

Case Number




Nature of Suit

Other Statutory Actions


Rya W. Zobel

Date Filed

August 29, 2002

Law Firms


Government Agencies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.